2024-03-28T22:29:01Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_D923E84BA601
2024-03-23T03:04:11Z
openaire
documents
urnserval
serval:BIB_D923E84BA601
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension.
10.1002/jbmr.1479
22113951
000300682500021
Papapoulos
S.
author
Chapurlat
R.
author
Libanati
C.
author
Brandi
M.L.
author
Brown
J.P.
author
Czerwiński
E.
author
Krieg
M.A.
author
Man
Z.
author
Mellström
D.
author
Radominski
S.C.
author
Reginster
J.Y.
author
Resch
H.
author
Román Ivorra
J.A.
author
Roux
C.
author
Vittinghoff
E.
author
Austin
M.
author
Daizadeh
N.
author
Bradley
M.N.
author
Grauer
A.
author
Cummings
S.R.
author
Bone
H.G.
author
article
2012
Journal of Bone and Mineral Research
1523-4681
0884-0431
journal
27
3
694-701
Aged
Antibodies, Monoclonal/adverse effects
Antibodies, Monoclonal/therapeutic use
Antibodies, Monoclonal, Humanized
Biological Markers/blood
Bone Density
Bone Density Conservation Agents/adverse effects
Bone Density Conservation Agents/therapeutic use
Cross-Over Studies
Double-Blind Method
Female
Humans
Osteoporosis/drug therapy
Placebos
Postmenopause
eng
60_published
Publication types: Clinical Trial, Phase III ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
https://serval.unil.ch/notice/serval:BIB_D923E84BA601
https://serval.unil.ch/resource/serval:BIB_D923E84BA601.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D923E84BA6014
Copying allowed only for non-profit organizations